Nozac (Nebivolol Hydrochloride)

Nebivolol Hydrochloride, the active ingredient in Nozac, is a beta blocker presented as an oral formulation for oral use. It is prescribed to lower elevated blood pressure in adult patients with hypertension. The drug combines selective β1‑adrenergic antagonism with nitric‑oxide‑mediated vasodilation, providing effective blood pressure control.

GNH USA supplies Nozac as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company ensures quality manufacturing, regulatory compliance, and reliable logistics for global distribution.

Nebivolol is used in the management of cardiovascular conditions, primarily hypertension.

Hypertension: reduces systolic and diastolic blood pressure by decreasing heart rate and promoting vasodilation.

Nebivolol may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Headache: mild to moderate pain often occurring early in therapy. - Dizziness: sensation of light‑headedness, especially when standing quickly. - Fatigue: general tiredness or reduced energy levels. - Nausea: upset stomach or urge to vomit.

Serious or Rare Side Effects: - Severe bradycardia: markedly slow heart rate that may require medical attention. - Hypotension: significant drop in blood pressure leading to fainting or shock. - Allergic reactions: rash, itching, swelling, or rare anaphylaxis.

When prescribing Nebivolol, several safety considerations should be observed.

Blood pressure monitoring: check BP regularly after initiation and dose changes. Discontinuation: avoid abrupt cessation to prevent rebound hypertension. Liver impairment: use caution and consider dose adjustment in severe hepatic dysfunction. Asthma or chronic obstructive pulmonary disease: monitor for bronchospasm as β1‑selectivity may not fully protect. Concomitant beta‑blockers: avoid combined use to prevent excessive cardiac depression. Store at ambient temperature: keep below 25 °C in original packaging, protect from moisture and light.

Nebivolol can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Other β‑blockers: additive cardiac depression. - Calcium channel blockers verapamil or diltiazem: increased risk of bradycardia and AV block. - Strong CYP2D6 inhibitors (e.g., paroxetine, fluoxetine): raise nebivolol plasma levels.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs: may reduce antihypertensive effect. - Diuretics: can potentiate hypotensive response, monitor electrolytes. - Other antihypertensives (ACE inhibitors, ARBs): may cause additive blood pressure lowering.